Article Figures & Tables
Tables
- Box 1: Absolute outcome comparisons among adults aged 65 years and older receiving SD-TIV and HD-TIV
Outcome SD-TIV HD-TIV Laboratory-confirmed influenza (1) 1.9% 1.4% Hospital admissions for laboratory-confirmed influenza (2) 1.10 per 10 000 person-weeks 0.86 per 10 000 person-weeks Post-influenza death (3) 0.038 per 10 000 person-weeks 0.028 per 10 000 person-weeks Mild adverse events* (4) 29.4% 34.3% Note: HD-TIV = high-dose trivalent inactivated influenza vaccine,
SD-TIV = standard-dose trivalent inactivated influenza vaccine.
↵* For example, fever, headache, malaise and myalgia.
Podcast